CIK 0001661181 · Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-26 | NUSSDORF GLENN H Director | Sale | −187,957 | $5.29 | $994K | 2,765,591 |
| 2025-11-25 | NUSSDORF GLENN H Director | Sale | −12,043 | $5.30 | $64K | 2,953,548 |
| 2025-11-24 | NUSSDORF GLENN H Director | Sale | −100,000 | $5.34 | $534K | 2,965,591 |
| 2025-08-11 | Grow Brian Chief Commercial Officer | Option exercise | +4,060 | $2.47 | $10K | 674,550 |
| 2025-08-11 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −2,173 | $4.62 | $10K | 672,377 |
| 2025-08-11 | Grow Brian Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −4,060 | 0 | ||
| 2025-07-16 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −360 | $4.47 | $2K | 189,165 |
| 2025-06-10 | NUSSDORF GLENN H Director | Sale | −18,620 | $3.56 | $66K | 335,719 |
| 2025-06-09 | NUSSDORF GLENN H Director | Sale | −4,156 | $3.50 | $15K | 354,339 |
| 2025-06-06 | Freedman Lori Chief Admin. and Legal Officer | Purchase | +9,022 | $2.99 | $27K | 846,459 |
| 2025-06-05 | Freedman Lori Chief Admin. and Legal Officer | Purchase | +142,379 | $2.91 | $414K | 837,437 |
| 2025-06-04 | Freedman Lori Chief Admin. and Legal Officer | Purchase | +100,863 | $2.82 | $285K | 695,058 |
| 2025-05-15 | NUSSDORF GLENN H Director | Purchase | +107,494 | $2.99 | $321K | 358,495 |
| 2025-05-14 | NUSSDORF GLENN H Director | Purchase | +251,001 | $3.09 | $775K | 251,001 |
| 2025-03-09 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −210 | $5.16 | $1K | 189,586 |
| 2025-03-09 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −61 | $5.16 | $315 | 189,525 |
| 2025-03-04 | Driscoll Michael Joseph Director | Sale | −25,000 | $5.10 | $128K | 166,879 |
| 2025-03-01 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −667 | $6.21 | $4K | 189,796 |
| 2025-02-19 | Cavorsi Robert Vice President, Strategy | Grant or award | +61,705 | 190,463 | ||
| 2025-02-19 | Cavorsi Robert Vice President, Strategy | Grant or award · Stock Option (Right to Buy) | +63,830 | 63,830 |
Page 5 of 12 · 228 trades